SALTORL (GORTEC 2014-03)
Trial closed to inclusions

Assessment of survival without laryngeal-esophageal dysfunction after 2 years in patients with resectable carcinoma of the larynx or hypopharynx.
Coordinator: Prof. Calais
Start date : 2015
Expected number of patients : 256

Access the Clinical Trials link

Access detailed information on the trial in the private section